InvestorsHub Logo
Followers 254
Posts 17959
Boards Moderated 0
Alias Born 01/19/2006

Re: biopharm post# 332494

Tuesday, 12/10/2019 4:57:49 PM

Tuesday, December 10, 2019 4:57:49 PM

Post# of 345969
Biopharm et al, take another look at the posters/abstracts/slides/presentations that either Dr. NK or Dr. TK(Precision for Medicine, a subsidiary of Perkin-Elmer) presented as co-authors at SITC or AACR a few years back. CJG may have them archived.

I recall posting here about an occasion that I attended/saw when a lady Ph.D. from Merck received a 15’ explanation from Dr. NK of the results shown on a particular poster at SITC or AACR. That poster dealt with the many immunotherapy targets that had been isolated from the failed Phase-3 trial of PPHM. I have always harbored the thought that MRK would become a clinical trial sponsor, in which Bavi would be involved, as a result of that dialogue between reps from MRK and PPHM.

Conspicuous by its absence was a discussion of the particular big 10 BP mentioned in yesterday’s conference call. I did not hear Bavi mentioned at all, or its role in filling Franklin, or its potential role in filling or partly filling the Milford reactors in the future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News